US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.41

+0.01000.00%

Post-market: 252.401.99+0.79%19:58 EDT

Volume:217.35K

Turnover:55.00M

Market Cap:494.43M

PE:- -

High:259.83

Open:253.12

Low:242.96

Close:250.40

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:0.83

T/O Rate:11.01%

Dividend:1.00

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)

Taixing Employee Medical Insurance Retirement Benefits: Everything You Need to Know

FDA-Driven Zanza Delay Keeps Exelixis Fairly Valued, Supporting Willey’s Hold Rating

Entero Healthcare Subsidiary Pays GST Penalty Under Protest, Plans Refund Claim

Syngene Schedules Analyst Meet at Kotak Healthcare Forum 2026

Scholar Rock announces FDA approval of isembyld

Press Release: Abrdn Healthcare Opportunities Fund (THQ) and Abrdn World Healthcare Fund (THW) Announce New Managed Distribution Policies and Declare Monthly Distributions

Health Care Flat as Traders Rotate Back into Fuel-Sensitive Sectors - Health Care Roundup

Health Care Roundup: Market Talk

Sector Update: Healthcare

MT Newswires Live

Pharming wins FDA nod to extend Joenja use to younger APDS children

FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.

Pharming Gets FDA Approval for Joenja to Treat APDS in Children Aged 4-11

MT Newswires Live

Health Care Roundup: Market Talk

FDA approves Joenja tablets for children aged 4-11 with APDS

Worldwide Healthcare Trust Boosts Treasury Stock with Latest Share Buyback

Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says

MT Newswires Live

Shanghai INT Medical Clarifies Sellers in Healthcare Equity Acquisition

Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":250.41,"timestamp":1789588800000,"preClose":250.4,"halted":0,"volume":217354,"hourTrading":{"tag":"盘后","latestPrice":252.4,"preClose":250.41,"latestTime":"19:58 EDT","volume":3855,"amount":968174.9559,"timestamp":1789603104098,"change":1.99,"changeRate":0.007947,"amplitude":0.007947},"delay":0,"changeRate":0.000039936102236385406,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Not Yet Opened","change":0.01,"latestTime":"09-16 16:00:00 EDT","open":253.12,"high":259.83,"low":242.96,"amount":54997599.92252,"amplitude":0.067372,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.4,"sharesOutstanding":3074486,"nav":250.283,"aum":494179857.69,"dividendRate":0.004,"bidAskSpread":0.002806,"preHourTrading":{"tag":"盘前","latestPrice":254.8128,"preClose":250.4,"latestTime":"09:28 EDT","volume":4289,"amount":1082884.5326099999,"timestamp":1789565312693,"change":4.4128,"changeRate":0.017623,"amplitude":0.012511},"postHourTrading":{"tag":"盘后","latestPrice":252.4,"preClose":250.41,"latestTime":"19:58 EDT","volume":3855,"amount":968174.9559,"timestamp":1789603104098,"change":1.99,"changeRate":0.007947,"amplitude":0.007947},"volumeRatio":0.831749,"impliedVol":0.9487,"impliedVolPercentile":0.6773},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.831749,"shares":1974486,"dividePrice":1.0016,"high":259.83,"amplitude":0.067372,"preClose":250.4,"low":242.96,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.41,"eps":0,"divideRate":0.004,"volume":217354,"delay":0,"ttmEps":0,"open":253.12,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":279.02,"twentyDayClose":289.98,"sixtyDayClose":230.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4588","MRNY","IEIH","IYH","BMED","TECB","BK4179","BK4585","IDNA","MRNX","XLVX","LABU","PINK","LFSC","NVIB","TLX","MEDI","PSCH","GDOC","GNMX","RSPH","FET","BK4139","IBB","TBXU","SYNB","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668081","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668081","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668081?lang=en_us&edition=fundamental","pubTime":"2026-09-14 01:20","pubTimestamp":1789320035,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Cooper Co (COO) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-cooper-co-coo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-cooper-co-coo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COO","BK4137","IE0009355771.USD","BK4581","IE00B4R5TH58.HKD","LU1992135472.HKD","XBI","LU2211815571.USD","IE0009354923.USD","IDNA","IE00BJJMRZ35.SGD","XLV","LU2272731600.USD","IE0002141913.USD","LU0128526141.USD","BK4198","IE00BJT1NW94.SGD","RVMD","LU0029874061.USD","HCSG","LU0320765992.SGD","LU0109394709.USD","BK4588","LU1992135399.USD","IE00BFTCPJ56.SGD","LABU","LU2272731782.SGD","LU0889565916.HKD","IE00B2B36J28.USD","BK4139","BBH","BK4585","GB00BDT5M118.USD","CANC","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170332650","title":"Taixing Employee Medical Insurance Retirement Benefits: Everything You Need to Know","url":"https://stock-news.laohu8.com/highlight/detail?id=1170332650","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170332650?lang=en_us&edition=fundamental","pubTime":"2026-09-13 10:50","pubTimestamp":1789267825,"startTime":"0","endTime":"0","summary":"Are you approaching retirement and wondering how your employee medical insurance benefits will be handled? The process involves specific eligibility criteria, payment top-up options, and contribution...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667575507","title":"FDA-Driven Zanza Delay Keeps Exelixis Fairly Valued, Supporting Willey’s Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2667575507","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667575507?lang=en_us&edition=fundamental","pubTime":"2026-09-13 01:45","pubTimestamp":1789235117,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Stephen Willey has maintained their neutral stance on EXEL stock, giving a Hold rating on September 1. Stephen Willey has g...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/fda-driven-zanza-delay-keeps-exelixis-fairly-valued-supporting-willeys-hold-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/fda-driven-zanza-delay-keeps-exelixis-fairly-valued-supporting-willeys-hold-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667502736","title":"Entero Healthcare Subsidiary Pays GST Penalty Under Protest, Plans Refund Claim","url":"https://stock-news.laohu8.com/highlight/detail?id=2667502736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667502736?lang=en_us&edition=fundamental","pubTime":"2026-09-13 01:14","pubTimestamp":1789233294,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Entero Healthcare Solutions Limited ( ($IN:ENTERO) ). Entero Healthcare Solutions has disclosed that its subsid...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/entero-healthcare-subsidiary-pays-gst-penalty-under-protest-plans-refund-claim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/entero-healthcare-subsidiary-pays-gst-penalty-under-protest-plans-refund-claim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GST","BK4581","BK4585","LABU","LU0029874061.USD","BK4588","HCSG","LU0128526141.USD","BK4137","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667950275","title":"Syngene Schedules Analyst Meet at Kotak Healthcare Forum 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667950275","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667950275?lang=en_us&edition=fundamental","pubTime":"2026-09-13 01:13","pubTimestamp":1789233202,"startTime":"0","endTime":"0","summary":"Syngene International Ltd. ( ($IN:SYNGENE) ) has issued an update. Syngene International Ltd. has scheduled a meeting with analysts and institution...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/syngene-schedules-analyst-meet-at-kotak-healthcare-forum-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/syngene-schedules-analyst-meet-at-kotak-healthcare-forum-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FET","LU0128526141.USD","BK4137","BK4179","LABU","XBI","LU0029874061.USD","XLV","BK4581","HCSG","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","THNR","BBP","MRNY","LFSC","IEIH","RSPH","IBB","GDOC","BK4588","TBXU","MRNX","IBRN","LABU","SYNB","BMED","PSCH","SRRK","NVIB","MEDI","TECB","GNMX","BK4139","FRTY","IYH","XLVX","IDNA","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666957293","title":"Press Release: Abrdn Healthcare Opportunities Fund (THQ) and Abrdn World Healthcare Fund (THW) Announce New Managed Distribution Policies and Declare Monthly Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2666957293","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666957293?lang=en_us&edition=fundamental","pubTime":"2026-09-12 05:37","pubTimestamp":1789162620,"startTime":"0","endTime":"0","summary":"PHILADELPHIA, Sept. 11, 2026 /PRNewswire/ -- abrdn Healthcare Opportunities Fund  and abrdn World Healthcare Fund   today announced that the Board of Trustees  has approved managed distribution policies designed to provide shareholders with transparent distribution frameworks aligned with each Fund's net asset value  and long-term return potential.Under the new policies, each Fund intends to make monthly distributions at an annualized rate of 10% of its average NAV per share during the preceding calendar month. Accordingly, the monthly distributions payable on September 30, 2026, to shareholders of record as of September 22, 2026 , will change:-- from $0.1800 per share to $0.17 per share for THQ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","THQ","DDDD","BK4581","BK4588","LABU","BK4585","XLV","CEFD","THW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666572306","title":"Health Care Flat as Traders Rotate Back into Fuel-Sensitive Sectors - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666572306","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666572306?lang=en_us&edition=fundamental","pubTime":"2026-09-12 05:22","pubTimestamp":1789161720,"startTime":"0","endTime":"0","summary":"Health-care companies were more or less flat as traders rotated back into sectors with more to gain from a drop in energy prices.French drug maker Ipsen is exploring the development of a U.S. manufacturing facility. The factory could produce Ipsen's Dysport product, a Botox competitor.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","LABU","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574467","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574467","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574467?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:50","pubTimestamp":1789159800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0409 ET - Novartis shares still trade at premium to those in Eur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XBI","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666792475","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666792475","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666792475?lang=en_us&edition=fundamental","pubTime":"2026-09-12 03:31","pubTimestamp":1789155086,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index down 0.3% and the State Street Health Care Select Sector SPDR ETF  easing 0.1%.The iShares Biotechnology ETF  rose 0.5%.In corporate news, Novo Nordisk  shares fell 2.2% after Morgan Stanley downgraded the stock to underweight from equal weight.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0267386448.USD","BK4581","LU1093756168.USD","LU0154236417.USD","NVOH","LU1791710400.SGD","LU0006306889.USD","LU0106831901.USD","NVOC","LU1244550494.USD","BK4504","LU2133065610.SGD","LU1244550221.USD","LU2487616109.SGD","PPH","LU0053666078.USD","LU1988902786.USD","THNR","LU2264538146.SGD","LU0106261372.USD","LU0795875169.SGD","LU1162221912.USD","LU1720051017.SGD","LU2271345857.HKD","LU0158827948.USD","XLV","LU2089284900.SGD","MS","LU0390134368.USD","LU0528227936.USD","LU2357305700.SGD","LU0912757837.SGD","LU1732799900.SGD","LU2347655156.SGD","LU1668664300.SGD","LU0971096721.USD","LU2111349929.HKD","LU1989772840.SGD","LU0234570918.USD","XBI","BK4588","IE00B3S45H60.SGD","LU0320765646.SGD","LU1720051108.HKD","LU0225283273.USD","LU1732800096.USD","BK4007","IE00BZ1G4Q59.USD","LU1989772923.USD","IBB","BK4599","OZEM","LU1064131342.USD","LU1074936037.SGD","BK4534","NVOX","LABU","BK4585","LU1548497426.USD","BK4532","LU2023251221.USD","BK4127","LU0314104364.USD","LU0557290698.USD","IE00B775SV38.USD","LU2028103732.USD","KBWB","LU0882574139.USD","IAI","LU0795875086.SGD","IE00BKVL7J92.USD","LU0158827781.USD","NVO","LU0098860793.USD","LU2089283258.USD","LU1363072403.SGD","LU0210528500.USD","LU1093756325.SGD","LU1244550577.SGD","LU1791710582.SGD","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","GDOC","FRTY","NVIB","BK4588","LABU","IDNA","RSPH","BMED","BBP","MRNX","BK4585","GNMX","PINK","MEDI","IEIH","IBB","MRNY","TBXU","XLVX","SYNB","PSCH","TECB","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666576737","title":"FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666576737","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666576737?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:00","pubTimestamp":1789149600,"startTime":"0","endTime":"0","summary":"FDA approval expands Joenja indication to include children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) ages 4 to 11 who weigh at least 27kgNewly approved Joenja doses are ex","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/11/3360484/0/en/fda-approves-pharming-s-joenja-as-first-treatment-for-children-with-apds-in-the-u-s.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666765235","title":"Pharming Gets FDA Approval for Joenja to Treat APDS in Children Aged 4-11","url":"https://stock-news.laohu8.com/highlight/detail?id=2666765235","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666765235?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:16","pubTimestamp":1789147000,"startTime":"0","endTime":"0","summary":"Pharming's  Joenja tablets have been approved to treat activated phosphoinositide 3-kinase delta syndrome, or APDS, in children 4-11 years who weigh at least 27 kg, the US Food and Drug Administration said Friday.Joenja was first approved in 2023 for the same indication in patients 12 years and older, the regulator said. APDS is a rare genetic disorder that impairs cells of the immune system.Shares were about 1.6% higher in afternoon trading.Price: 10.98, Change: +0.17, Percent Change: +1.60","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","PHAR","BK4139","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575978","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575978?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:20","pubTimestamp":1789143600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0409 ET - Novartis shares still trade at premium to those in Eur","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575157","title":"FDA approves Joenja tablets for children aged 4-11 with APDS","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575157","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575157?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:15","pubTimestamp":1789143312,"startTime":"0","endTime":"0","summary":"The FDA announced that it has approved Joenja tablets as the first treatment for activated phosphoinositide 3-kinase delta syndrome in children 4-1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-joenja-tablets-for-children-aged-4-11-with-apds-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-joenja-tablets-for-children-aged-4-11-with-apds-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575974","title":"Worldwide Healthcare Trust Boosts Treasury Stock with Latest Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575974","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575974?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:07","pubTimestamp":1789142844,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) has provided an update. Worldwide Healthcare Trust PLC has executed a share buyback, purchasing 48...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-latest-share-buyback-6?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-latest-share-buyback-6?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BRKC","XBI","BRKU","BRKL","XLV","BK4585","BK4137","BK4581","BRKD","HCSG","ACKY","LU0029874061.USD","LU0128526141.USD","ACTV","BRKW","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257316","title":"Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257316","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257316?lang=en_us&edition=fundamental","pubTime":"2026-09-11 23:33","pubTimestamp":1789140826,"startTime":"0","endTime":"0","summary":"Definium Therapeutics'  upcoming phase 3 data on DT120 in generalized anxiety disorder or GAD is likely to further de-risk the program and back potential approval, RBC Capital Markets said in a Friday note.The first phase 3 trial in GAD met its primary endpoint and a positive data readout from the second phase 3 trial should ease residual regulatory uncertainty on the therapy's approvability, the brokerage said. Data from the second phase 3 trial is due for release \"any day now,\" RBC noted.Trial results are likely to support approval from the US Food and Drug Administration given DT120's robust efficacy data, well-powered studies, and the FDA's flexibility for neuropsychiatric drugs, according to the investment firm.RBC has an outperform rating on Definium Therapeutics, with a $66 price target.Price: 38.53, Change: +0.80, Percent Change: +2.12","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","DFTX","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666736525","title":"Shanghai INT Medical Clarifies Sellers in Healthcare Equity Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666736525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666736525?lang=en_us&edition=fundamental","pubTime":"2026-09-11 23:08","pubTimestamp":1789139337,"startTime":"0","endTime":"0","summary":"Shanghai Kindly Medical Instruments Co., Ltd. Class H ( ($HK:1501) ) has provided an announcement. Shanghai INT Medical Instruments Co., Ltd., a Ho...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/shanghai-int-medical-clarifies-sellers-in-healthcare-equity-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/shanghai-int-medical-clarifies-sellers-in-healthcare-equity-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","BK4585","LU0029874061.USD","EQR","BK4581","BK4215","BK4137","INT","LU0128526141.USD","REZ","BK4138","HCSG","BK4588","XLV","LINT","INYY","INTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666352286","title":"Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666352286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666352286?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medicus-pharma-ltd-mdcx-and-labcorp-holdings-lh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medicus-pharma-ltd-mdcx-and-labcorp-holdings-lh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","XLV","LABU","BK4581","LU0251142724.SGD","LU0251131958.USD","BK4139","BK4196","LU0029874061.USD","LU0048573561.USD","BK4588","LU0128526141.USD","LU1059921491.USD","HCSG","LU0006061336.USD","XBI","BK4585","BK4550","BK4137","LU2237438978.USD","LH","LU0742534661.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":8,"totalSize":411,"code":"91000000","status":"200"}]}}